Association between riboflavin intake and the risk of all-cause mortality of patients with chronic kidney disease: A retrospective cohort study.
- 2024-09-27
- Observational · n = 3,750
- Medicine 103(39)
- Xiaoxu Ren
- Rong Wang
- Fen Liu
- Quanzhen Wang
- Hairong Chen
- Yunfeng Hou
- Lifeng Yu
- Xiangchun Liu
- Zhiming Jiang
- PubMed: 39331893
- DOI: 10.1097/md.0000000000039417
- High evidence
- Clinical
Lower intake of riboflavin was associated with the higher risk of all-cause mortality (Q1: HR = 1.33, 95% CI: 1.05-1.69).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes